Vimentin is an endogenous ligand for the pattern recognition receptor Dectin-1

Cardiovascular Research

Volumn 99, Issue 3, 2013, Pages 494-504

  Thiagarajan, Praveena S ^a,b   Yakubenko, Valentin P ^a,c   Elsori, Deena H ^a,d   Yadav, Satya P ^a   Willard, Belinda ^a   Tan, Carmela D ^a   Rene Rodriguez E ^a   Febbraio, Maria ^a   Cathcart, Martha K ^a,b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b KENT STATE UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d ABU DHABI UNIVERSITY   (United Arab Emirates)

Author keywords

Alarmins; Atherosclerosis; Dectin 1; Extracellular vimentin; Superoxide anion

Indexed keywords

ANTIBODY; DECTIN 1; OXYGEN; SUPEROXIDE; UNCLASSIFIED DRUG; VIMENTIN; ZYMOSAN ANTIBODY; CHOLESTEROL; CLEC7A PROTEIN, HUMAN; LECTIN; LIGAND; PATTERN RECOGNITION RECEPTOR; PROTEIN BINDING; ZYMOSAN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CAROTID ATHEROSCLEROSIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; INFLAMMATION; MACROPHAGE; MASS SPECTROMETRY; MOLECULAR PATHOLOGY; MONOCYTE; NECROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; TWO DIMENSIONAL GEL ELECTROPHORESIS; CAROTID ARTERY OBSTRUCTION; IMMUNOLOGY; LIPID METABOLISM; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; ALARMINS; DECTIN-1; EXTRACELLULAR VIMENTIN; PROTEIN BINDING;

CAROTID STENOSIS; CHOLESTEROL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; IMMUNOBLOTTING; LECTINS, C-TYPE; LIGANDS; LIPID METABOLISM; MACROPHAGES; OXIDATION-REDUCTION; PROTEIN BINDING; RECEPTORS, PATTERN RECOGNITION; SUPEROXIDES; VIMENTIN; ZYMOSAN;

ALARMINS; ATHEROSCLEROSIS; DECTIN-1; EXTRACELLULAR VIMENTIN; SUPEROXIDE ANION;

EID: 84888206284     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt117     Document Type: Article

References (42)

1. Johnston RB Jr, Godzik CA, Cohn ZA. Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med 1978;148: 115-127.
2. Elsori DH, Yakubenko VP, Roome T, Thiagarajan PS, Bhattacharjee A, Yadav SP et al. Protein kinase C{delta} is a critical component of Dectin-1 signaling in primary human monocytes. J Leukoc Biol 2011;90:599-611.
3. Xu XH, Shah PK, Faure E, Equils O, Thomas L, Fishbein MC et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 2001;104:3103-3108.
4. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002;105:1158-1161.
5. Porto A, Palumbo R, Pieroni M, Aprigliano G, Chiesa R, Sanvito F et al. Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J 2006;20:2565-2566.
6. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007;81:1-5.
7. Lundberg AM, Hansson GK. Innate immune signals in atherosclerosis. Clin Immunol 2010; 134:5-24.
8. Lotze MT, Deisseroth A, Rubartelli A. Damage associated molecular pattern molecules. Clin Immunol 2007;124:1-4.
9. Ehrchen JM, Sunderkotter C, Foell D, VoglT, RothJ. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 2009;86:557-566.
10. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005;5:331-342.
11. ScheibnerKA, LutzMA, BoodooS, FentonMJ, Powell JD, HortonMR.Hyaluronanfragments act as an endogenous danger signal by engaging TLR2. J Immunol 2006;177:1272-1281.
12. Okamura Y, Watari M, Jerud ES, YoungDW, Ishizaka ST, Rose J et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001;276:10229-10233.
13. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000;164:558-561.
14. Shelton MD, Mieyal JJ. Regulation by reversible S-glutathionylation: molecular targets implicated in inflammatory diseases. Mol Cells 2008;25:332-346.
15. Robinson MJ, Sancho D, Slack EC, LeibundGut-Landmann S, Reis e Sousa C. Myeloid C-type lectins in innate immunity. Nat Immunol 2006;7:1258-1265.
16. Yokota K, Takashima A, Bergstresser PR, Ariizumi K. Identification of a human homologue of the dendritic cell-associated C-type lectin-1, dectin-1. Gene 2001;272:51-60.
17. Ariizumi K, Shen GL, Shikano S, Xu S, Ritter R 3rd, Kumamoto T et al. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J Biol Chem 2000;275:20157-20167.
18. Brown GD, Gordon S. Immune recognition. A new receptor for beta-glucans. Nature 2001;413:36-37.
19. Sancho D, Joffre OP, Keller AM, Rogers NC, Martinez D, Hernanz-Falcon P et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 2009;458:899-903.
20. Weber K, Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem 1969;244:4406-4412.
21. Li Q, Subbulakshmi V, Fields AP, Murray NR, Cathcart MK. Protein kinase calpha regulates human monocyte O-2 production and low density lipoprotein lipid oxidation. J Biol Chem 1999;274:3764-3771.
22. Pick E, Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods 1981;46:211-226.
23. Carnevale KA, Cathcart MK. Protein kinase C beta is required for human monocyte chemotaxis to MCP-1. J Biol Chem 2003;278:25317-25322.
24. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, InsullWJr et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995;15: 1512-1531.
25. Kinter MS, Sherman NE. Protein Sequencing and Identification Using Tandem Mass Spectrometry. New York: Wiley-Interscience 2000;Chapter 6.
26. Keightley JA, Shang L, Kinter M. Proteomic analysis of oxidative stress-resistant cells: a specific role for aldose reductase overexpression in cytoprotection. Mol Cell Proteomics 2004;3:167-175.
27. Mor-Vaknin N, Punturieri A, Sitwala K, Markovitz DM. Vimentin is secreted by activated macrophages. Nat Cell Biol 2003;5:59-63.
28. Karlsson R, Katsamba PS, Nordin H, Pol E, Myszka DG. Analyzing a kinetic titration series using affinity biosensors. Anal Biochem 2006;349:136-147.
29. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, SorescuGPet al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002; 105:1429-1435.
30. Harris HE, Raucci A. Alarmin(g) news about danger: workshop on innate danger signals and HMGB1. EMBO Rep 2006;7:774-778.
31. Cambi A, Figdor C. Necrosis: C-type lectins sense cell death. Curr Biol 2009;19: R375-R378.
32. Moisan E, Girard D.Cell surface expressionof intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis. J Leukoc Biol 2006;79:489-498.
33. Plummer EM, Thomas D, Destito G, Shriver LP, Manchester M. Interaction of cowpea mosaic virus nanoparticles with surface vimentin and inflammatory cells in atherosclerotic lesions. Nanomedicine (Lond) 2012;7:877-888.
34. Muller K, Dulku S, Hardwick SJ, Skepper JN, Mitchinson MJ. Changes in vimentin inhuman macrophages during apoptosis induced by oxidised low density lipoprotein. Atherosclerosis 2001;156:133-144.
35. Xu B, deWaal RM, Mor-Vaknin N, Hibbard C, Markovitz DM, Kahn ML. The endothelial cell-specific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature. Mol Cell Biol 2004;24:9198-9206.
36. Mahesh B, Leong HS, McCormack A, Sarathchandra P, Holder A, Rose ML. Autoantibodies to vimentin cause accelerated rejection of cardiac allografts. Am J Pathol 2007; 170:1415-1427.
37. Huet D, Bagot M, Loyaux D, Capdevielle J, Conraux L, Ferrara P et al. SC5 mAb represents a unique tool for the detection of extracellular vimentin as a specific marker of Sezary cells. J Immunol 2006;176:652-659.
38. Gottfried E, Kunz-Schughart LA, Weber A, Rehli M, Peuker A, Muller A et al. Expression of CD68 in non-myeloid cell types. Scand J Immunol 2008;67:453-463.
39. Perides G, Harter C, Traub P. Electrostatic and hydrophobic interactions of the intermediate filament protein vimentin and its amino terminus with lipid bilayers. J Biol Chem 1987;262:13742-13749.
40. Nishimura N, Balch WE. A di-acidic signal required for selective export from the endoplasmic reticulum. Science 1997;277:556-558.
41. Garg A, Barnes PF, Porgador A, RoyS, WuS, Nanda JS et al. Vimentin expressedonmycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor. J Immunol 2006;177:6192-6198.
42. Ise H, Kobayashi S, Goto M, Sato T, Kawakubo M, TakahashiMet al. Vimentin and desmin possess GlcNAc-binding lectin-like properties on cell surfaces. Glycobiology 2010;20: 843-864.